Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines | Zendy

Jennifer M. Radin | Zendy; Anthony W. Hawksworth | Zendy; Patrick J. Blair | Zendy; Dennis J. Faix | Zendy; Rema Raman | Zendy; Kevin L. Russell | Zendy; Gregory C. Gray | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Dramatic Decline of Respiratory Illness Among US Military Recruits After the Renewed Use of Adenovirus Vaccines

Author(s) -

Jennifer M. Radin,

Anthony W. Hawksworth,

Patrick J. Blair,

Dennis J. Faix,

Rema Raman,

Kevin L. Russell,

Gregory C. Gray

Publication year - 2014

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciu507

Subject(s) - medicine , respiratory illness , respiratory system , military personnel , covid-19 , military medicine , intensive care medicine , immunology , virology , disease , infectious disease (medical specialty) , outbreak , political science , law

In late 2011, after a 12-year hiatus, oral vaccines against adenovirus types 4 (Ad4) and 7 (Ad7) were again produced and administered to US military recruits. This study examined the impact of the new adenovirus vaccines on febrile respiratory illness (FRI) and adenovirus rates and investigated if new serotypes emerged. FRI rates and their associated hospitalizations had markedly risen since vaccine production ceased in 1999.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research